CRL — Charles River Laboratories International, Inc. stock price, charts and financials

QT78Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. (NYSE: CRL) is a Healthcare company in the Medical - Diagnostics & Research industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
278.06
-3.61-1.28%
OverviewShort InterestFilings
CRLQT78Charles River Laboratories International, Inc.·NYSE
278.06-1.28%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 27, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13GBeneficial ownership statement (passive)
Aug 11, 20264Statement of changes in beneficial ownership
Aug 11, 20264Statement of changes in beneficial ownership
Aug 10, 20264Statement of changes in beneficial ownership
Aug 10, 20264Statement of changes in beneficial ownership
Aug 06, 20264Statement of changes in beneficial ownership
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 01, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 405
Page
▼
/ 17